Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

634
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
634
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.4K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

310
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
310

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Exploratory Pilot Study of Coagulation- and Fibrinolysis-Related Proteins in Unexplained Infertility.

International journal of molecular sciences·2026
Same author

Therapeutic Effects of Glucagon-like Peptide-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: A Systematic Review.

International journal of molecular sciences·2026
Same author

An Exploratory Study of Heat Shock Protein Changes in Women with Unexplained Infertility.

International journal of molecular sciences·2026
Same author

Correlation Between Thyroid Nodule Size and Risk of Thyroid Cancer: A Retrospective Cohort Study at a Tertiary Care Center.

Diagnostics (Basel, Switzerland)·2026
Same author

Double-Blind Placebo-Controlled Randomized Study of Sporopollenin Exine (SpEC) Fragrance Encapsulation.

Pharmaceutics·2026
Same author

Metformin Treatment Potentially Modifies Genetically Driven Metabolite-HbA1c Associations: A Gene-Environment Interaction Mendelian Randomization Study.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Video

Updated: Aug 14, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.6K

Hypoglycemia-induced changes in complement pathways in type 2 diabetes.

Abu Saleh Md Moin1, Manjula Nandakumar1, Ilhame Diboun2

  • 1Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.

Atherosclerosis Plus
|January 16, 2023
PubMed
Summary

Hypoglycemia elevates complement pathway proteins in type 2 diabetes (T2D), suggesting inflammation drives cardiovascular risk. In controls, complement proteins influence inflammation.

Keywords:
Complement proteinsHypoglycemiaProteomicsType 2 diabetes

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.8K
Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

4.9K

Related Experiment Videos

Last Updated: Aug 14, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

1.6K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.8K
Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

4.9K

Area of Science:

  • Endocrinology and Immunology
  • Cardiovascular Medicine

Background:

  • Hypoglycemia is linked to cardiovascular events.
  • The role of complement pathway proteins in hypoglycemia is not well understood.
  • This study investigates complement protein changes during hypoglycemia in type 2 diabetes (T2D).

Purpose of the Study:

  • To test the hypothesis that circulating complement proteins are elevated in response to hypoglycemia in T2D.
  • To explore the relationship between hypoglycemia, inflammation, and complement activation in T2D patients and controls.

Main Methods:

  • A prospective study involving 23 T2D patients and 23 controls.
  • Insulin-induced hypoglycemia was administered, with blood samples collected at baseline, during hypoglycemia, and post-hypoglycemia.
  • SOMAscan proteomic analysis was used to measure complement pathway proteins, cytokines, and inflammatory proteins.

Main Results:

  • Elevated levels of Complement C2 and Factor B were observed at baseline in T2D patients.
  • During hypoglycemia, Complement C2, Factor B, and Factor I increased in T2D patients.
  • Granger causality analysis indicated that inflammatory proteins drove complement changes in T2D, while complement proteins drove inflammatory changes in controls.

Conclusions:

  • Upregulation of the complement pathway, evidenced by elevated C2 and Factor B, is present in T2D.
  • Hypoglycemia-induced changes in complement proteins suggest pathway activation driven by inflammation in T2D.
  • These findings may contribute to understanding cardiovascular events associated with hypoglycemia in T2D.